Qatar Biobank is considered one of the leading personalized medicine programs in the world. They collect data and samples from the local population to help develop customized medical solutions to health issues prevalent in the country. BC Platforms will provide a collaborative research platform to enable integration of genomic and phenotypic samples, secure data access, and optimize resource quality and utilization. BC Platforms is a Debiopharm Innovation Fund portfolio company.
